drugset / Trial / NCT00983580
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
RandomizedParallel-groupDouble-blindPrevention
Summary
This phase II trial is studying how well giving acetylsalicylic acid together with eflornithine works in treating patients at high risk for colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acetylsalicylic acid and eflornithine may prevent colorectal cancer.
Timeline
- Start
- 2009-08-20
- Primary completion
- 2016-10-07
- Completion
- 2019-08-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | — | Oral |
| Subject | Eflornithine | Small molecule | — | Oral |